ResMed dominates the global sleep apnea device market, boasting a 50–60% share and a high-margin razor-razor-blade business ...

During the holidays, I love spending time in the kitchen, using all my favorite devices to bake cookies and other treats that remind me of past Christmas celebrations. With a stand mixer, food ...

In support of World COPD Day on November 19, the Global Initiative for Chronic Obstructive Lung Disease (GOLD), is drawing attention to the importance of correctly diagnosing COPD earlier - with the ...

GSK’s respiratory drug lineup spans a newly approved product for chronic obstructive pulmonary disease as well as therapeutic candidates in various stages of clinical development for treating this ...

Are you getting quality sleep? When you wake in the morning, do you feel refreshed, or do you feel tired and lack energy during the day? “I strongly encourage our patients, regardless of age, weight ...

FRANKENMUTH, Mich. – rtNOW has launched rtNOW Engage, a suite of turnkey service lines to support durable medical equipment (DME) companies, including follow-up checks for non-invasive ventilation ...

Chronic obstructive pulmonary disease, or COPD, is the fourth leading cause of death worldwide, responsible for 3.5 million deaths in 2021, according to the World Health Organization. It’s a common ...

Having recently scored approval for Nucala in chronic obstructive pulmonary disease (COPD), GSK has now signed a major $12 billion biobucks deal designed to strengthen the pharma’s offering for the ...

COPD affects at least 4.5% of those 18-49 years old, according to an analysis of U.S. cohorts. The early COPD group was more likely to be hospitalized or die from chronic respiratory disease, to ...

Roche’s hopes of getting its chronic obstructive pulmonary disease (COPD) drug astegolimab to regulators this year have taken a hit after the anti-ST2 monoclonal antibody failed to reduce flare-ups in ...